Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG-Fresenius add-on therapy for Graves' orbitopathy
2007-005261-35Phase 2Terminated
- Sponsor
- Fresenius
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit in Graves' ophthalmopathy (TED), sponsored by Fresenius. Started Jul 2008; status: terminated.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
Graves' ophthalmopathy (TED)
Beyond the preview
Go deeper on 2007-005261-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005261-35.